The latest closing stock price for BridgeBio Pharma as of September 20, 2024 is 26.74.
An investor who bought $1,000 worth of BridgeBio Pharma stock at the IPO in 2019 would have $-29 today, roughly 0 times their original investment - a -0.60% compound annual growth rate over 5 years.
The all-time high BridgeBio Pharma stock closing price was 72.35 on February 08, 2021.
The BridgeBio Pharma 52-week high stock price is 44.32, which is 65.7% above the current share price.
The BridgeBio Pharma 52-week low stock price is 21.62, which is 19.1% below the current share price.
The average BridgeBio Pharma stock price for the last 52 weeks is 29.41.
An investor who bought $1,000 worth of BridgeBio Pharma stock at the IPO in 2019 would have $-29 today, roughly 0 times their original investment - a -0.60% compound annual growth rate over 5 years.
The all-time high BridgeBio Pharma stock closing price was 72.35 on February 08, 2021.
The BridgeBio Pharma 52-week high stock price is 44.32, which is 65.7% above the current share price.
The BridgeBio Pharma 52-week low stock price is 21.62, which is 19.1% below the current share price.
The average BridgeBio Pharma stock price for the last 52 weeks is 29.41.